Clinical Trial

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of PROCTOeze® PLUS

Completed
View on ClinicalTrials.gov →
Summary
This trial aims to evaluate the overall performance and safety of the MD PROCTOeze® PLUS in relieving symptomatology of haemorrhoidal disease and anal irritation in adult patients affected by Grade I-II (Goligher classification) haemorrhoids as assessed by the patient and the Investigator at the end of the treatment period.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-18; most recent amendment 2026-02-04.
Trial Details
NCT Number NCT06944951
Lead Sponsor Biokosmes Srl
Conditions Haemorrhoidal Disease
Enrollment 50 participants
Start Date 2024-11-05
Primary Completion 2025-01-17 (estimated)
Study Completion 2025-01-17 (estimated)
Updated on ClinicalTrials.gov 2026-02-05